Akari Therapeutics (FRA:CLA) Purchase Of Investment : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Akari Therapeutics Purchase Of Investment?

Akari Therapeutics's purchase of investment for the three months ended in Dec. 2024 was €0.00 Mil. It means Akari Therapeutics spent €0.00 Mil on purchasing investments. Akari Therapeutics's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Sep. 2024 ), Akari Therapeutics spent the same money on purchasing investments in Dec. 2024 (€0.00 Mil).

Akari Therapeutics Purchase Of Investment Historical Data

The historical data trend for Akari Therapeutics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akari Therapeutics Purchase Of Investment Chart

Akari Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Purchase Of Investment

Get a 7-Day Free Trial

Akari Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Purchase Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Akari Therapeutics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Akari Therapeutics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Akari Therapeutics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Akari Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akari Therapeutics PLC (FRA:CLA) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

AKTX:USA

Address

22 Boston Wharf Road, Boston, MA, USA, 02210

Website

https://www.akaritx.com

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).